Mojtaba Akhtari

University of Nebraska Medical Center
Division of Oncology/Hematology
987680 Nebraska Medical Center
Lied Transplant Center
Omaha, NE

842 Trend Analysis of 5-Year All-Cause Mortality After Autologous Stem Cell Transplantation in Patients with Lymphoma and Multiple Myeloma
2040 A Retrospective Analysis Comparing BEAM Versus Melphalan Prior to First Autologous Peripheral Blood Hematopoietic Stem Cell Transplant in Newly Diagnosed Multiple Myeloma Patients